Oncolytics Biotech (Canada)
Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Oncolytics Biotech (Canada), Canada, covering academic research published from 2000 to 2025. Read More.
Open Access Percentage
47%
Total
Publications
245
Total Open
Publications
116
Total
Citations
7.4K
Open Access
Percentage
47%
Total
Publications
245
Total Open
Publications
116
Total
Citations
7.4K
Breakdown
Publisher Open
11%
Both
29%
Other Platform Open
7%
Closed
53%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 48%
47
Hybrid 27%
26
No Guarantees 25%
24
Other Platform Open
Domain 73%
65
Institution 42%
37
Preprint 7%
6
Other Internet 7%
6
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 66 |
doaj.org OAI-PMH Repository | Institution | 32 |
DOI | Other Internet | 5 |
Research Square | Preprint | 3 |
medRxiv | Preprint | 2 |
California Digital Library | Institution | 2 |
Unknown Repository | Other Internet | 1 |
University of Arizona | Institution | 1 |
University College London | Institution | 1 |
The University of Melbourne | Institution | 1 |